Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,341 | -860 | -3,145 | -2,371 | -1,663 |
| Depreciation Amortization | 337 | 210 | 553 | 341 | 162 |
| Other Working Capital | 987 | 644 | 1,654 | 1,240 | 790 |
| Other Operating Activity | -68 | -16 | -18 | -11 | 22 |
| Operating Cash Flow | $-85 | $-23 | $-956 | $-801 | $-689 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -38 | N/A | 11 | 31 | 67 |
| Debt Issued | 25 | N/A | 829 | 762 | 541 |
| Common Stock Issued | N/A | N/A | 117 | 117 | 117 |
| Other Financing Activity | 97 | 22 | 0 | -110 | -5 |
| Financing Cash Flow | $84 | $22 | $957 | $800 | $720 |
| Beginning Cash Position | 1 | 1 | 1 | 1 | 1 |
| End Cash Position | 0 | 0 | 1 | 1 | 32 |
| Net Cash Flow | $-1 | $-1 | $1 | $0 | $31 |
| Free Cash Flow | |||||
| Operating Cash Flow | -85 | -23 | -956 | -801 | -689 |
| Free Cash Flow | -85 | -23 | -956 | -801 | -689 |